Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Tadalafil and Finasteride may help treat aggressive melanoma.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Afatinib often causes skin problems that need proactive management.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Warfarin can rarely cause hair loss, which is usually reversible.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.